SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-120837"
 

Search: onr:"swepub:oai:DiVA.org:uu-120837" > The angiogenic grow...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patients

Sköldenberg, Erik G. (author)
Uppsala universitet,Institutionen för kirurgiska vetenskaper
Larsson, Anders (author)
Uppsala universitet,Klinisk kemi
Jakobson, Åke (author)
show more...
Hedborg, Fredrik (author)
Uppsala universitet,Institutionen för genetik och patologi
Kogner, Per (author)
Karolinska Institutet
Christofferson, Rolf H. (author)
Uppsala universitet,Institutionen för kvinnors och barns hälsa,Barnkirurgi/Christofferson
Azarbayjani, Faranak (author)
Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
show less...
 (creator_code:org_t)
2009
2009
English.
In: Anticancer Research. - 0250-7005 .- 1791-7530. ; 29:8, s. 3311-3319
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • AIM: To determine whether concentrations of the angiogenic growth factors hepatocyte growth factor (HGF) and vascular endothelial growth factor A (VEGF-A) correlate with clinical and genetic markers in samples taken at diagnosis in children with neuroblastoma (NB). PATIENTS AND METHODS: Heparin plasma (P-) and serum (S-) samples of healthy controls (n=73, mean age +/- SD 3.5+/-2.1; females/males: 23/50) and patients with NB (n=62; 2.2+/-1.8; 26/36) were collected between 1988 and 1999. Clinical data included age at diagnosis, gender, stage, outcome, amplification of the oncogene MYCN, loss of heterozygosity at the short arm of chromosome 1 (1p LOH) and ploidy. RESULTS: HGF and S-VEGF-A were elevated in NB as compared to controls (38/62 patients, p<0.0001 and p<0.05, Mann-Whitney U test). HGF concentrations were higher in high-stage (stage 3-4) as compared to low-stage (stage 1-2) disease (p<0.01). P-HGF was elevated in patients with 1p LOH (p<0.01), MYCN amplification (p<0.001) and di- or tetraploidy (p<0.001). S-HGF concentration was elevated in patients MYCN-amplified tumors only. Plasma and S-HGF concentrations were higher in the deceased group (p<0.05), but not P or S-VEGF-A. CONCLUSION: This study showed that concentrations of HGF and S-VEGF-A are elevated in patients with NB. Furthermore, HGF and S-VEGF-A concentrations correlate to higher stage disease and HGF correlates to genetic markers known to indicate a poor outcome. These observations imply that HGF and VEGF-A have biological roles in NB and suggest the possibility of interference with HGF or VEGF-A signaling as a therapeutic strategy.

Keyword

Angiogenesis factor
hepatocyte growth factor
vascular endothelial growth factor
tumor markers
MEDICINE
MEDICIN

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view